Viewing Study NCT06429995



Ignite Creation Date: 2024-06-16 @ 11:47 AM
Last Modification Date: 2024-10-26 @ 3:30 PM
Study NCT ID: NCT06429995
Status: ENROLLING_BY_INVITATION
Last Update Posted: 2024-05-28
First Post: 2023-09-22

Brief Title: Standard Follow-up Program SFP for Breast Cancer Patients
Sponsor: University Medical Center Groningen
Organization: University Medical Center Groningen

Study Overview

Official Title: Standard Follow-up Program SFP for Breast Cancer Patients
Status: ENROLLING_BY_INVITATION
Status Verified Date: 2024-05
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: SFPMAMMA
Brief Summary: Motive

In order to improve the treatment technique a comprehensive follow-up program is needed to obtain all relevant patient treatment and toxicity data from breast cancer patients

Goalto set-up and maintain a database containing treatment results in terms of tumor control side effects complications and patient-reported quality of life

A standard database of patiƫnts receiving photon treatment will be created These data are then linked to dose-volume data of radiotherapy with the aim to build prediction models for both tumor control and toxicity after radio chemo therapy that can later be used for selecting patients for proton treatment

To set-up and maintain a database containing treatment results in terms of tumor control side effects complications and patient-reported quality of life

A standard database of patients receiving photon treatment will be created These data are then linked to dose-volume data of radiotherapy with the aim to build prediction models for both tumor control and toxicity after radio chemo therapy that can later be used for selecting patients for proton treatment
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None